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Summary Tenascin, a novel six-armed extracellular matrix glycoprotein, was immunohistochemically exam-
ined in the human normal adult colon, and colonic neoplasms such as tubular adenomas, primary and
metastatic adenocarcinomas. In contrast to previous reports, tenascin was hardly detectable in the normal
adult colons, being predominantly localised in the fibrous stroma surrounding the glandular epithelia of the
neoplastic lesions. The neoplastic cells themselves were totally negative for tenascin expression. Both the
tubular adenoma tissues and the superficial layer of well-differentiated adenocarcinomas in general were
intensely reactive to tenascin antibody, and the staining intensity increased as the adenoma became more
atypical in cases of tubular adenomas. By pretreatment of the paraffin-embedded tissue sections with pepsin,
the distribution of tenascin was often intensified considerably and distinct localisation was more clearly
demonstrated in the colonic tumour tissues. Tenascin was also biochemically purified from human invasive
colonic carcinomas, and this cancerous tissue tenascin was compared with that extracted from a human
umbilical cord fibroblast cell line in terms of molecular heterogeneity. Two major isoforms of the purified
tenascin from colonic cancer tissues were found to have relative molecular masses of 250 kD and 190 kD,
which were almost identical to those of human foetal fibroblast tenascin glycoproteins. In addition, several
lower molecular weight isoforms were frequently detectable in the cancerous tissues, which might represent
immuno-reactive tenascin isoforms proteolytically digested in human colonic carcinomas in vivo.
Tenascin (TN) (Chiquet-Ehrismann et al., 1986) is an extra-
cellular matrix (ECM) glycoprotein with a unique six-armed
macromolecular structure and an unusually restricted tissue
distribution. During foetal development, TN is produced by
mesenchyme adjacent to actively growing epithelia, and in
adult tissues, it is found in the stroma of benign and malig-
nant tumours (Chiquet-Ehrismann et al., 1986; Mackie et al.,
1987). These findings suggest that TN may be an oncofoetal
protein that plays an important role in cell-to-cell com-
munication in the process ofproliferation and migration, and
characterises embryonic morphogenesis as well as tumour cell
invasion and metastasis. We previously demonstrated that
some membrane-associated enzymes such as alkaline phos-
phatase and 5'-nucleotidase were produced by stromal cells
of chemical carcinogen-induced gastric adenocarcinomas in
rats (Hirota et al., 1989a, 1989b; Sakai et al., 1991), and
these enzymes were sometimes co-expressed with TN (N.
Hirota and T. Sakai, unpublished work). TN is also the
multifunctional glycoprotein, participating in cell adhesion
and repulsion, guidance along cell migration pathways, epi-
thelial cell shedding from surfaces, demarcation of tissue
boundaries, promotion of cell growth, and hemagglutination
(Erickson & Lightner, 1988; Erickson & Bourdon, 1989). In a
previous study, we demonstrated that TN purified from
human foetal umbilical cord fibroblast cultures was com-
posed of two kinds of isoforms with relative molecular
masses of 250 kD and 190 kD (Oike et al., 1990). Thus,
considering these reports together, the temporal, spatial dis-
tribution and multifunctional roles of TN molecule raise an
important biological question. Is TN from human cancerous
tissues different from that derived from human normal foetal
stromal cells such as fibroblasts? In the present study, tissue
distribution of TN from colonic tissues was investigated by
immunohistochemical staining. We also examined molecular
differences between TNs from various colon cancers with
reference to their histological patterns. Here we report that
major TN isoforms from well- and moderately-differentiated
adenocarcinomas were found to have relative molecular
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weights identical to those of human normal foetal fibroblasts,
and that TN from poorly-differentiated and mucinous types
of colon cancers contain some immuno-reactive isoforms
proteolytically digested in human colonic carcinomas in vivo.
Materials and methods
Antibodies
The following primary antibody preparations were used in
this study: (1) monoclonal rat antibody (RCB 1, IgG2a
isotype) to TN purified from human umbilical cord fibroblast
cell line, HUCF-p2 (Oike et al., 1990); and (2) polycloncal
rabbit antibody to fibronectin (FN) (Organon Teknika N.V.,
West Chester, NY).
Immunohistochemistryfor TN
Neoplastic and non-neoplastic samples were derived from
surgically resected materials. They included 15 normal
colons, eight hyperplastic polyps, 20 adenomas, 30 adenocar-
cinomas (26 well- or moderately-differentiated adenocarcin-
omas, including metastatic lesions of lymph-nodes, and four
poorly-differentiated adenocarcinomas), and eight mucinous
carcinomas. The materials were immediately fixed in 10%
buffered formalin, embedded in paraffin, and sectioned at a
thickness of 3ism. Sections were deparaffinised in xylene, and
rehydrated in a graded ethanol series (100-50%) followed by
a rinse in water. Then they were pretreated with 0.4% pepsin
(Sigma Chem. Co., St. Louis) in 0.01 M HCI for 2 h at 37'C,
and briefly rinsed in water. In order to inactivate endogenous
peroxidase enzyme, sections were immersed in methanol con-
taining 0.3% hydrogen peroxide for 30 min at room tempera-
ture. After three 10 min washes in phosphate-buffered saline
(PBS), sections were incubated in PBS containing 10% nor-
mal goat serum, pH 7.4 for 30 min to block nonspecific
protein binding. Slides were washed again in PBS, and the
primary antibody was applied to each section overnight at
4°C. Monoclonal rat antibody to TN was diluted 1:100.
Normal rat serum was used as negative control primary
antibody. After incubation in primary antibody, slides were
washed three times in PBS, and a secondary antibody layer
composed of biotinylated goat anti-rat IgG (diluted 1:500)
(Organon Teknika N.V., West Chester, NY) was applied for
40 min at room temperature. Slides were washed again, and
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treated with horseradish peroxidase-conjugated avidin-biotin
complex (ABC) (DAKOPATTS, A/S., Denmark) for 40 min
at room temperature. A final wash in PBS was performed,
and slides were incubated in a freshly prepared chromogen
solution containing 0.1% 3,3'-diaminobenzidine tetrahydro-
chloride (Dojindo Lab., Japan) and 0.02% hydrogen perox-
ide in 50 mM Tris-HCI pH 7.6. Sections were counterstained
with haematoxylin or methyl green, and mounted with glass
coverslips for photomicrography. Some sections were not
pretreated with pepsin, and the pretreatment effects on the
immunoreactivity were studied.
Extraction of TNfrom human colonic carcinomas
Surgically obtained material from eight advanced colonic
adenocarcinomas was used for extraction and purification of
TN (five well- or moderately-diflhrentiated adenocarcinomas,
two mucinous carcinomas and one poorly-differentiated ad-
enocarcinoma) (Table I). Fresh cancer tissues were cut into
2-3 mm3 by a razor blade, and then extraction buffer (4 M
urea, 0.15 M NaCl, 50 mM Tris-HCI pH 7.4, 2 mM phenyl-
methanesulfonyl fluoride (PMSF)) was added to the tissues
(10 ml buffer per g of tissue). They were stirred for 12 h at
4°C, and the precipitates were removed by centrifugation at
15,000 g for 40min at 4°C.
Gel filtration Crude TN fractions in the extracts were
obtained by gel filtration. Extracts were applied to Sepharose
CL-4B column (2.5 x 110 cm, Pharmacia LKB Biotech, Swe-
den), which had been equilibrated with 4 M urea, 0.15 M
NaCI, 50 mM Tris-HCI pH 8.0, 2 mM PMSF, 0.2% (w/v)
3-[3-cholamidopropyl)-diemtylammonio]- 1-propanesulfonate
(CHAPS). The elution was performed at a flow rate of
20 ml h-' with monitoring of absorption at 280 nm. The
concentration of protein was meausured by the bicinchoninic
acid (BCA) method (Smith et al., 1985), and immunoreac-
tivity with both TN and FN antibodies was examined by
immunoblotting.
Gelatin affinity gel chromatography In order to remove FN
from TN-enriched fractions, gelatin affinity gel chromatog-
raphy was performed by the method described previously
(Oike et al., 1990), with a slight mpdification. Briefly, TN-
enriched fractions were concentrated to 1/10 volume with
CentriCell (Polyscience, Inc., Warrington), and then dialysed
against 100 volumes of 0.5 M urea, 0.15 M NaCl, 50mM
Tris-HCI pH 7.4, 2 mM PMSF and 0.2% (w/v) CHAPS for
overnight at 4°C. The dialysate was incubated with gelatin
Sepharose 4B gel (Pharmacia LKB Biotech., Sweden) (1 ml
gel for 1 mg protein) for overnight at 4°C with rotating at
100 r.p.m. The gel-containing solution was poured into a
glass column (1 x 10 cm), and washed with 5 bed volumes of
ice cold dialysed buffer. Fractions that passed through the
column were collected and concentrated to 1/10 volume with
CentriCell, and then dialysed against 100 volumes of gel
filtration buffer without 0.15 M NaCl for overnight at 4°C.
Ion exchange high performance liquid chromatogra-
phy DEAE-5PW column (1 cm x 5 cm, Toso, Japan) was
equilibrated with 4 M urea, 50 mM Tris-HCl pH 8.0 at a flow
rate of 0.5 mlmin-'. Samples were loaded and elution was
achieved with an ascending gradient of 4 M urea, 1 M NaCl,
50 mM Tris-HCl pH 8.0: 0-40% in 40 min and 40-100% in
10 min. The elution was monitored by absorption at 280 nm.
The distribution of immunogenicity for TN was determined
by immunoblotting.
SDS-PAGE and immunoblotting Reduced samples were pre-
pared as follows: samples (10 mg as protein) were dissolved in
10 yl of 50 mM Tris-HCl pH 6.8, 1% (v/v) 2-mercapto-
ethanol, 2% (w/v) sodium dodecyl sulfate, 20% (w/v) gly-
cerol, 0.04% (w/v) bromophenol blue and were heated at
100°C for 3 min. The electrophoresis unit was a model of the
vertical slab gel electrophoresis (Dai-ichi Pure Chem., Japan).
Samples were applied to 4-20% (w/v) sodium dodecyl sul-
fate polyacrylamide gradient gels. Electrophoresis (Laemmli,
1970) was at 10 mA for 10 min to load samples then 30 mA
until the tracking dye was near the end of the gel. Immuno-
blotting was performed by the following procedure of Tow-
bin et al. (1979). TN bands on sodium dodecyl sulfate
polyacrylamide gel electrophoresis (SDS-PAGE) were trans-
ferred onto Immobilon-P transfer membrane (Millipore
Corp., Bedford, MA) with Trans-Blot Cell (Bio-Rad Lab.,
Richmond, CA) at 30 V for overnight at 4°C. The membrane
was washed three times in PBS containing 0.5% bovine
serum albumin (BSA, fraction V) (Sigma Chem. Co., St.
Louis) and 0.1% polyoxyethylene sorbitan monolaurate
(Tween 20). In order to block nonspecific protein binding,
the membrane was incubated in PBS containing 3% normal
goat serum, 0.5% BSA and 0.1% Tween 20 for 30 min at
room temperature, and then incubated in primary antibody
overnight at 4°C. Monoclonal rat antibody to TN was
diluted 1:200 in PBS containing 3% BSA and 0.05% Tween
20. After incubation in primary antibody, the membrane was
washed three times, and incubated in a secondary antibody
composed of peroxidase-conjugated goat anti-rat IgG (dilu-
ted 1:400) (Organon Teknika, N.V., West Chester, NY) for
2.5 h at room temperature. For visualisation of immunoreac-
tive bands, the membrane was incubated in a freshly pre-
pared chromogen solution containing 3,3'-diaminobenzidine
tetrahydrochloride plus cobalt chloride (Sigma Chem. Co.,
St. Louis), and 0.02% hydrogen peroxide in 50 mM Tris-HCl
pH 7.6.
Results
Immunohistochemical localisation of TN in human normal
adult colons and colonic neoplastic lesions
Expression of TN was found to be almost negative in the
normal adult colonic mucosa, as shown in Figure 1. In the
region of subepithelial lamina propria and muscularis mu-
Table I Clinicopathological findings of surgically resected advanced colonic
carcinomas used for extraction and purification of tenascin
Patient Age Pathological findings
number (yrs) Sex Portion Histological findings
1 85 F Ascending colon Moderately-differentiated
adenocarcinoma (Dukes B)
2 59 M Rectum Papillary adenocarcinoma
(Dukes B)
3 64 F Sigmoid colon Well-differentiated
adenocarcinoma (Dukes C)
4 42 M Sigmoid colon Papillary adenocarcinoma
(Dukes C)
5 44 M Rectum Moderately-differentiated
adenocarcinoma (Dukes B)
6 56 F Transvers colon Mucinous carcinoma (Dukes B)
7 66 M Sigmoid colon Mucinous carcinoma (Dukes C)
8 75 F Ascending colon Poorly-differentiated
adenocarcinoma (Dukes C)1060 T. SAKAI et al.
Figure 1 A histochemical reaction for TN antibody in the nor-
mal adult colon, using monoclonal antibody (RCB 1) against
human TN. The expression of tenascin is found to be almost
negative. x 58.
cosa with inflammatory or regenerative changes, only mini-
mal expression, if any, was detectable.
As shown in Figure 2, immunoreactivity of TN was found
to be localised preferentially in the fibrous stroma surroun-
ding the glandular epithelia of the neoplastic lesions. In
general, the most intense reaction for TN antibody was
demonstrated in the fibrous stroma of both tubular adeno-
mas and the superficial layer of well-differentiated adenocar-
cinomas (Figure 2a-c). In particular, in cases of tubular
adenoma, the staining intensity increased as the adenoma
a
b
became more atypical in contrast to almost completely
negative immunoreactivity in the hyperplastic areas (Figure
2a and b). Hyperplastic polyps were almost free of immuno-
reactivity except for those showing inflammatory changes
(data not shown). The typical staining pattern of TN was
demonstrated in the tubules of adenocarcinomas, outlining
the border of the tubules (Figure 2d). TN staining was also
invariably seen in the muscularis mucosa, the wall of sub-
mucosal blood vessels including arterioles, and the muscularis
propria in addition to the fibrous stroma within the neoplas-
tic lesions (Figure 3a). Moreover, the non-neoplastic mucosae
near cancerous lesions showed the same positive reactions
(Figure 3b). Those positive reactions gradually became
weaker however, as the non-neoplastic mucosae became more
distant from the cancerous lesions.
The intensity of TN immunostaining in the stroma charac-
teristic of invasive well- and moderately-differentiated adeno-
carcinomas varied from area to area, and both the TN
staining pattern and its stromal localisation were not depen-
dent on the degree of tumour differentiation. However, in
poorly-differentiated adenocarcinomas, which were rich in
fibrous stroma, the reaction with TN antibody was almost
negative (Figure 3c). In contrast, there was a prominent
positive reaction with TN antibody in the stroma, including
the capsule adjacent to the tubules, and the wall of vessels in
the metastatic foci of the lymph-nodes of well- or moder-
ately-differentiated adenocarcinomas (Figure 3d). No
significant difference in the staining pattern was found
between primary tumours and secondary lesions in lymph-
nodes. The results of these immunohistochemical studies are
summarised in Table II. TN was undetectable in the plasma
membrane and cytoplasm of all the neoplastic epithelial cells.
C
d
Figure 2 Histochemical reactions for TN antibody of tubular adenomas and well-differentiated adenocarcinoma, using RCB1. a
and b, tubular adenomas. Note the clear positive expression in the fibrous tissue stroma of the neoplastic lesion, and the negative
reaction in the hyperplastic area (arrows, a,). The staining intensity is increased as the adenoma becomes more atypical (b). x 58 c,
Well-differentiated adenocarcinoma. The immunoreactive localisation of TN is found especially in the superficial layer. x 58 d,
Tubular adenoma of focal malignant transformation. The localisation of TN is demonstrated in the typical staining pattern
outlining the malignantly transformed tubules. x 118.C
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Figure 3 Immunoreactive localisation of TN in primary and metastatic colonic adenocarcinomas, using RCB-1. a, TN is detected
in the muscularis mucosa, the wall of submucosal blood vessels including arterioles, and muscularis propria within the neoplastic
lesion. x 58 b, Non-neoplastic mucosa near the lesions of adenocarcinoma shows the same immunoreactive localisations. x 31. c,
Poorly-differentiated adenocarcinoma. The reaction for TN antibody is found to be almost negative. x 139. d, Metastatic foci of
moderately-differentiated adenocarcinoma in lymph-node. The prominent positive reaction) for TN antibody is present in the
fibrous tissue stroma, and the wall of vessels including the capsule adjacent to metastatic tubules. x 38.
mm, muscularis mucosa; ar, arteriole; ca, carcinoma; mp, muscularis propria.
Table II Expression of tenascin in human colonic non-neoplastic
and neoplastic tissues by immunohistochemical analysis
Cases Intensity of
Histological types studied tenascin expressiona
Non-neoplastic tissues
Normal adult colon 15 (-)
Hyperplastic polyp 8 (-)-(+)
Neoplastic tissues
Adenoma
Mild atypia 5 +-+ +
Moderate atypia 9 + + + + +
Severe atypiab 6 + + +
Adenocarcinoma
Well-differentiated 11 + ++ -+ +
Moderately-differentiated 15 + +-+
Poorly-differentiated 4 (-)-(+)
Mucinous carcinoma 8 (+)- +
aThe number of + signs denotes relative intensity of immunostain-
ing when compared against the intensity in other histological types.
bIncluding the cases of tubular adenoma having the malignantly
transformed foci. (+), weak positive expression; (-), almost
negative expression.
By pretreatment of the paraffin-embedded tissue sections with
pepsin, the distribution of TN was considerably intensified
and the distinct localisation of TN was more clearly demon-
strated in colonic tumour tissues (Figure 4a and b).
Comparison of TNs extractedfrom human colonic carcinomas
Table I shows eight cases of advanced colonic carcinomas,
the TN of which was extracted and purified. Two typical gel
filtration profiles on Sepharose CL-4B of ECM glycoproteins
were shown in Figure 5 (5a, case 1: moderately-differentiated
adenocarcinoma; and Sb, case 6: mucinous carcinoma). The
protein profile was determined by BCA assay and the
immunoreactivity with both TN and FN antibodies was
examined by immunoblotting. The peak fraction of TN
preceded that of FN (Figure 5), and the contents of both TN
and FN in the cases of well- and moderately-differentiated
adenocarcinomas (cases 1-5) were definitely higher than
those of the mucinous and poorly-differentiated adenocar-
cinomas (cases 6-8) (data not shown). In each case, TN-
enriched fractions termed Fraction A (Figure 5a), were col-
lected, concentrated with CentriCell. Gelatin Sepharose 4B
affinity chromatography was performed in order to remove
FN from Fraction A. Then the fraction was applied to
DEAE-5PW ion-exchange HPLC column. Three major peaks
(termed Fractions I, II and III) were found on the elution
pattern in the case 1 (Figure 6a). Immunoblotting for TN
demonstrated that Fraction I was the most TN-enriched
peak, and the major protein bands in Fraction I were found
to have apparent molecular weights of 250 and 190 kD. In
addition, some lower-molecular weight bands were observed
(Figure 6b). Fraction I was collected, concentrated and
analysed for immunogenicity by immunoblotting. As shown
in Figure 7, both major isoforms of the purified TN showed
the relative molecular masses of 250 and 190 kD in the cases1062 T. SAKAI et al.
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Figure 4 Serial sections immunostained for TN, to compare
pretreatment effects. a, Without pretreatment by pepsin. TN
immunoreactivity is almost absent in paraffin-embedded sections
of well-differentiated adenocarcinoma, using TN antibody RCB
1. x 58. b, In contrast to a, pretreatment of the section with
pepsin restores TN immunoreactivity as evidenced by the intense
positive expression in the fibrous tissue stroma. x 58.
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Figure 5 Two typical gel filtration profiles on Sepharose CL-4B
chromatography of ECM glycoproteins. a, case I (the moder-
ately-differentiated adenocarcinoma); b, case 6 (the mucinous
carcinoma). (Inset) Relative quantitations of immunoreactivity
with TN monoclonal antibody RCB-l (shaded histograms) and
FN polyclonal antibody (light histograms) in the immunoblotting
analysis. TN-enriched fractions which were analysed for further
investigations (Fraction A) show the hatched box (a).
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Figure 6 a, DEAE-5PW ion-exchange column chromatography of Fraction A in the case I after gelatin Sepharose 4B chromatog-
raphy. Elution was monitored at 280 nm absorbance. b, Immunoblotting analysis of Fraction I in the case l. Fractions from
number 35 to 45 in DEAE-5PW ion-exchange column chromatography were analysed by using TN monoclonal antibody RCB I
under reducing conditions. Arrows indicate the position of the molecular weight.
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Figure 7 Immunoblotting analysis of Fraction I in each case
(cases I to 8) under reducing conditions, using TN monoclonal
antibody RCB 1. Arrows indicate the position of the molecular
weight.
of well- and moderately-differentiated adenocarcinomas
(cases 1-5). However, in case 6, only the subunit with the
molecular weight of 190 kD was found, and in cases 7 and 8
(the mucinous carcinoma and the poorly-differentiated
adenocarcinoma, respectively) neither major isoform was
readily detectable. In addition to the two major isoforms,
several lower molecular weight isoforms, which ranged from
130 to 40 kD, were frequently detectable in almost all colonic
carcinomas.
Discussion
The present studies demonstrated that expression of TN was
almost undetectable by immunohistochemistry in normal
adult colonic mucosa. Pepsin-treatment was performed since
it has been frequently untilised in order to intensify TN
expression (Barskey et al., 1984). However, no distinct local-
isation of TN was demonstrated in any cases whether or not
the normal tissue sections were pretreated with pepsin. This
finding does not agree with the previous reports showing that
TN was present in the basement membrane of the superficial
epithelium, muscularis mucosa and muscle layer of the nor-
mal adult colons (Oike et al., 1990; Natali et al., 1991). This
discrepancy might be explained as follows: the monoclonal
antibody to human TN used by Natali et al. (1991) recog-
nised different epitopes from ours. In fact, our TN antibody
could detect TN produced by human breast carcinoma cell
line MDA-MB-231 although their antibody could not (Kaw-
akatsu et al., 1992). Oike et al. (1990) used autopsy material
for their imunohistochemical studies. Such materials might
have not only inflammatory and/or regenerative changes but
also some post-mortem modifications. It is well known that
TN is expressed during wound healing (Mackie et al., 1988;,
Murakami et al., 1989), and our present data also sometimes
demonstrated weak positive expression in the inflammatory
and regenerative mucosae. As a general feature, most inter-
stitial fibroblasts express no detectable levels of TN, sugges-
ting that, in normal conditions, its synthesis is shut off in
these cells (Erickson & Bourdon, 1988; Natali et al., 1991).
Our current immunohistochemical findings in the normal
adult colon are completely consistent with these reports.
In contrast to the absence of TN in the normal colonic
mucosa, its expression was clearly demonstrated in human
colonic neoplasms in immunohistochemical studies. The most
distinct localisation of TN was shown in the stroma of
tubular adenomas and of the superficial layer of well-
differentiated adenocarcinomas. In tubular adenomas in par-
ticular, TN staining intensity increased as their histology
became more atypical, which may suggest an involvement of
TN in the process of malignant transformation of the neo-
plastic colonic epithelial cells. However, TN immunostaining
intensity in invasive well- and moderately-differentiated aden-
ocarcinomas was weaker and varied from area to area
whereas the metastatic foci of lymph-nodes in these' car-
cinomas showed a prominent expression of TN with its
staining pattern being not significantly different from that of
the primary lesions.
Mackie et al. (1987) reported that TN expression was
prominent in the stroma of human malignant breast tumours
but not in the benign ones such as fibroadenomas. Howeedy
et al. (1990) recently showed similar results, and the hetero-
geneous distribution of TN was observed in squamous cell
carcinomas of skin with prominent expression in the dermal
papillae of Bowen's disease (Anbazhagan et al., 1990). These
reports suggest that TN might be a stromal marker for
malignancy. However, in our present investigation, TN ex-
pression decreased relatively during malignant progression of
invasive colonic adenocarcinomas: in fact, immunoreactivity
for TN antibody was almost absent'in poorly-differentiated
adenocarcinomas in spite of the richness of fibrous stroma.
The pattern of TN expression in the colonic neoplasms,
which is different from that in breast and skin tumours, may
be reflected by the organ specificity during carcinogenesis:
e.g. a malignant transformation often occurs in colon aden-
omas but not in breast fibroadenomas and skin tumours.
By pretreatment of the paraffin-embedded tissue sections
with pepsin, the distribution of TN was often considerably
intensified and the distinct immunoreactive localisation was
more clearly demonstrated (Figure 4a and b). It is known
that the basement membrane zone antigens, which are ECM
components, are selectively enhanced by pretreatment with
pepsin in the formalin-fixed and paraffin-embedded sections,
whereas pretreatment by other proteases such as trypsin and
collagenase is ineffective (Barsky et al., 1984). Our present
studies also demonstrated that pretreatment by pepsin in the
formalin-fixed, paraffin-embedded sections was an effective
method to unmask the TN antigenic sites. This enables us to
investigate various lesions retrospectively, including rare
cases of many diseased tissues embedded for years in
paraffin.
There is a correlation in the content between TN and FN
in each case in gel filtration, and the content of TN is also
considered to represent the histochemical reactivity of TN in
the stroma surrounding adenocarcinoma cells. In fact, the
intensity of TN immunostaining in invasive adenocarcinomas
seemed to reflect the content of TN in the purified fractions.
The two major molecular isoforms of purified TN from
advanced human colon cancers w'ere composed of 250 kD
and 190 kD under reducing conditions, which were identical
to those of human foetal fibroblast (Oike et al., 1990). This
may suggest identity of the protein species and may justify
consideration of TN as an oncofoetal antigen. Several other
lower molecular weight forms, which ranged from 130 kD to
40 kD, were also identified as the immuno-reactive TN in the
colonic carcinomas. These lower molecular weight molecules
may be proteolytically-digested TN isoforms or alternatively-
spliced or post-translationally-modified forms. There is a well
established concept that tumour invasion and metastasis
require enzymatic degradation of the host interstitial matrix.
The dissociation of the tumour cells depends on changes both
in the ECM surrounding the primary tumour and in the
adhesive property of the tumour cells themselves (Liotta,
1986; Tryggvason et al., 1987; Hart et al., 1989). It is also1064 T. SAKAI et al.
known that an advancing front of invasive tumour cells can
also induce secretion of hydrolytic enzymes from their adja-
cent non-tumour host cells (Moscatelli & Rifkin, 1988; Blood
& Zetter, 1990). Recently, Basset et al. (1990) suggested that
stromelysin-3 may be an enzyme which degrades ECM in
cancers to play an important part in progression of epithelial
malignancy, and raised the possibility that stromelysin-3 acts
on TN during the invasive phase ofcancer. If this is the case,
the decreased content of TN in poorly-differentiated adeno-
carcinomas, including mucinous carcinomas of colon (cases
6-8), might result from the high enzyme activity in these
cancer tissues to digest the TN molecules. On the other hand,
as demonstrated in chicken (Pearson et al., 1988), mouse
(Weller et al., 1991; Saga et al., 1991) and human (Siri et al.,
1991) TN molecules, there are several isoforms derived from
alternative splicing of precursor mRNA of the FN type
III-like domain or from post-translational modification of the
polypeptide with N-linked carbohydrate moieties. Further
studies remain to be done to determine the pathobiological
significance of the interaction between epithelial cells and
surrounding ECM, especially TN during colonic carcino-
genesis, and proliferation or infiltration of carcinoma cells of
the colon.
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